Lewes, DE -- (SBWIRE) -- 06/13/2017 -- Report forecast the global short bowel syndrome (SBS) market to grow at a CAGR of 25.53% during the period 2017-2021.

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition. Based on drug class, the market is segmented into GLP-2, growth hormone, glutamine, and others.

The report covers the present scenario and the growth prospects of the global short bowel syndrome (SBS) market for 2017-2021. To calculate the market size, the report considers the sales of the drugs and related nutraceutical products.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

According to the report, one of the major drivers for this market is special drug designations. As the market is dominated by a few drugs and the pipeline also demonstrates the same, the special designation will provide more opportunity for revenue generation and to expand geographically. These designations carry benefits such as an extension of patent exclusivity period to address the need for an orphan drug, tax credits of up to 50% of R&D costs, and orphan drug's sponsors are exempted from paying the US FDA application fees. These benefits will reduce the burden from vendors to develop a product for a rare disease.

Further, the report states that one of the major factors hindering the growth of this market is severe side effects of the drugs. The side effects involved in the use of GATTEX may hinder the adoption rates. GATTEX is a GLP-2 analog used for the treatment of adult patients with SBS who are dependent on parenteral support. There is an increased risk that abnormal cells could become cancer. The few other side effects associated with GATTEX is swelling (inflammation) or blockage in gallbladder or pancreas or fluid overload. These side effects could lead to trouble in having a bowel movement or passing gas, stomach area (abdomen) pain or swelling, nausea, vomiting, swelling, and blockage in stoma opening.

Global Short Bowel Syndrome (SBS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global short bowel syndrome (SBS) market: Emmaus Medical, Merck, and Shire.

Other Prominent Vendors in the market are: Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio Pharmaceuticals, and Zealand Pharma.

Market driver
- Special drug designations
- For a full, detailed list, view our report

Market challenge
- Severe side effects of the drugs
- For a full, detailed list, view our report

Market trend
- Increased awareness of GI disorders
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages "Global Short Bowel Syndrome (SBS) Market 2017 - 2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Orphan drug designation, Pipeline landscape, Market segmentation by route of administration (ROA), Market segmentation by drug class, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Please visit this link for more details: http://www.marketresearchreports.com/technavio/global-short-bowel-syndrome-sbs-market-2017-2021

For related reports please visit: Bowel Syndrome Market Research Reports

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.
Market Research Reports® Inc. is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements: http://www.marketresearchreports.com/contact